General Principles - The purpose of the decision-making system for related transactions is to standardize related transactions of Guangzhou Weili Medical Equipment Co., Ltd., protect the legitimate rights and interests of the company, shareholders, and creditors, and ensure fairness in decision-making [1][2] - Related transactions refer to the transfer of resources or obligations between the company, its controlling subsidiaries, and related parties [1][2] Definition of Related Parties - Related parties include both legal entities and natural persons that have a significant influence or control over the company [1][2] - Legal entities that are considered related parties include those directly or indirectly controlling the company, those controlled by such entities, and those with significant shareholding [1][2] - Natural persons considered related parties include shareholders holding more than 5% of shares, directors, and senior management [2][3] Reporting and Approval Procedures - Directors and senior management must report related party lists and relationships to the board of directors in a timely manner [3][6] - Related transactions must be disclosed and approved by a majority of independent directors before being submitted to the board for review [7][10] - The board must ensure that related directors abstain from voting on related transactions [9][10] Decision-Making Authority - The company is prohibited from providing financial assistance to related parties, except under specific conditions [12][15] - Transactions involving amounts exceeding 30 million yuan or 0.5% of the company's net assets must be reviewed by the board [15][20] - The company must disclose audit or evaluation reports for transactions exceeding 30 million yuan [20][14] Exemptions from Approval - Certain transactions, such as those providing unilateral benefits without obligations, may be exempt from the approval process [28][18] - Transactions with related parties that do not exceed specified thresholds may also be exempt from detailed scrutiny [28][18] Implementation and Amendments - The decision-making system will be implemented after approval by the shareholders' meeting, and previous related transaction decision-making systems will be automatically invalidated [31][18]

广州维力医疗器械股份有限公司 章程 广州维力医疗器械股份有限公司 章程 （二〇二五年八月修订） 广州维力医疗器械股份有限公 司 章程 目 录 广州维力医疗器械股份有限公司 章程 第一章 总则 第一条 为维护公司、股东、职工和债权人的合法权益，规范公司的组织和 行为，根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中华人 民共和国证券法》（以下简称"《证券法》"）和其他有关规定，制定本章程。 第二条 广州维力医疗器械股份有限公司（以下简称"公司"）系经广州市 对外贸易经济合作局穗外经贸资[2011]482号《关于中外合资企业广州市韦士泰 医疗器械有限公司改制为外商投资股份制企业的批复》批准，由广州市韦士泰医 疗器械有限公司（系中外合资企业）整体变更设立的股份有限公司。在公司登记 管理机关注册登记，取得营业执照，公司统一社会信用代码为 广州市韦士泰医疗器械有限公司原有股东为公司发起人。 第三条 公司于2015年1月30日经中国证券监督管理委员会（以下简称"中国 证监会"）证监许可【2015】197号文核准，首次向社会公众公开发行人民币普通 股2500万股，于2015年3月2日在上海证券交易所上市。 第四 ...

Core Viewpoint - The document outlines the compensation management system for directors and senior management at Guangzhou Weili Medical Equipment Co., Ltd., aiming to enhance management stability and align individual performance with the company's long-term interests [1][2]. Group 1: General Principles - The compensation system is designed to improve the incentive and restraint mechanisms for directors and senior management, ensuring alignment with the company's operational goals and sustainable development [1]. - The principles of the compensation system include: 1. Compensation determined by position value 2. Performance evaluation standards 3. Alignment of individual compensation with long-term company interests 4. Balance of incentives and constraints [1]. Group 2: Compensation Management Structure - The Board of Directors is responsible for reviewing the compensation of senior management, while the shareholders' meeting reviews the compensation of directors [2]. - The Compensation and Assessment Committee of the Board is tasked with establishing evaluation standards and compensation policies for directors and senior management [2]. Group 3: Compensation Standards - Director compensation varies based on specific roles and contributions, with independent directors receiving a stipend approved by the shareholders' meeting [4]. - Senior management compensation consists of a base salary and performance-based pay, calculated as: Annual Compensation = Base Salary + Performance Pay [4]. Group 4: Compensation Distribution - Compensation for directors and senior management is distributed according to internal policies, with independent director stipends paid monthly after approval [6]. - Performance pay may be withheld under certain conditions, such as public reprimands or significant violations of regulations [6]. Group 5: Compensation Adjustment - Adjustments to compensation are based on industry salary trends, inflation, company profitability, organizational changes, and individual role changes [8]. - The Board may establish temporary rewards or penalties for specific circumstances as a supplement to regular compensation [8]. Group 6: Miscellaneous Provisions - The compensation management system is subject to relevant laws and regulations, and it becomes effective upon approval by the shareholders' meeting [9][10].

General Principles - The investment management system aims to enhance the management of external investments, standardize investment behavior, improve investment efficiency, and maximize the time value of funds [1][2] - External investments refer to various forms of investment activities made by the company to obtain future returns, involving monetary funds, equity, and assessed physical or intangible assets [1] Investment Types - Investments are categorized into short-term and long-term based on the duration, with short-term investments being those that can be liquidated within one year, and long-term investments exceeding one year [1] - Long-term investments include independent enterprises, joint ventures, equity stakes in other entities, and asset leasing or joint operations [1] Approval Authority - The company implements a professional management and hierarchical approval system for external investments [2] - The board of directors and the shareholders' meeting are the main decision-making bodies for external investments, operating within their respective authority [2] Investment Approval Standards - Investments meeting certain thresholds must be submitted for board review, including asset totals exceeding 10% of the latest audited total assets or net assets, and transaction amounts exceeding 10% of net assets with absolute amounts over 10 million [3][4] - For significant transactions, board approval is required before submission to the shareholders' meeting if they exceed 50% of total assets or net assets, or if profits exceed 50% of the latest audited net profit [4][5] Organizational Management - The board's strategic committee is responsible for coordinating and organizing analyses of external investment projects [5] - The general manager leads the investment review team, responsible for collecting information, preliminary evaluations, and establishing a project database [5] Financial and Legal Management - The finance department manages the financial aspects of external investments, including handling funding procedures and registrations [6] - Legal advisors are responsible for reviewing agreements and contracts related to external investments [6] Investment Transfer and Recovery - The company can recover investments under specific circumstances, such as project completion, bankruptcy, or force majeure [7] - Investment transfers must comply with legal and internal regulations, with the same approval procedures as initial investments [7] Collaboration with Investment Institutions - Joint investments with professional institutions require timely disclosure and adherence to relevant approval processes [8][9] - The company must disclose significant developments related to joint investments, including fundraising outcomes and major changes in investment funds [9] Information Disclosure - The company must comply with disclosure obligations as per regulatory requirements, ensuring transparency in investment projects that deviate from business direction or show continuous losses [10] - The board secretary and office are responsible for managing information disclosure related to external investments [10]

Core Viewpoint - The external guarantee management system of Guangzhou Weili Medical Equipment Co., Ltd. aims to protect investors' rights, regulate external guarantee behaviors, and prevent risks associated with external guarantees [1]. Group 1: General Principles - The external guarantee refers to the guarantees provided by the company for others, including guarantees for subsidiaries, and can take forms such as guarantees, mortgages, and pledges [1]. - The system applies to the company and its subsidiaries, requiring subsidiaries to report external guarantee matters to the company before board or shareholder meetings [1]. - The company must adhere to principles of legality, prudence, mutual benefit, and safety in external guarantees, with strict risk control measures [2]. Group 2: Decision-Making Authority - External guarantee matters must be reviewed by the board of directors or the shareholders' meeting [2]. - The board has the authority to approve external guarantees not listed in specific conditions, requiring a majority of directors' consent [2][3]. - Shareholder meetings must approve guarantees exceeding 10% of the latest audited net assets or 50% of total assets, among other conditions [3][4]. Group 3: Application and Review Procedures - The company must assess the credit status of the guaranteed party and conduct a risk evaluation before deciding on guarantees [6]. - The finance department is responsible for the initial review and daily management of guarantee applications [7]. - The board of directors must carefully consider and control the debt risks associated with external guarantees, potentially hiring external professionals for risk assessment [8]. Group 4: Daily Management and Risk Control - Written contracts must be established for external guarantees, ensuring compliance with relevant laws and clear terms [8]. - The finance department is tasked with ongoing monitoring of the financial status of the guaranteed party during the guarantee period [10]. - If the guaranteed party fails to fulfill obligations, the company must take necessary remedial actions [11]. Group 5: Miscellaneous Provisions - The system will take effect after approval by the shareholders' meeting, replacing the previous external guarantee management system [12].

Core Points - The document outlines the rules for the board of directors of Guangzhou Weili Medical Equipment Co., Ltd, aiming to standardize the decision-making process and enhance the board's operational efficiency [1][2][3] Group 1: Meeting Types and Procedures - The board meetings are categorized into regular and temporary meetings, with at least one regular meeting required in each half of the year [2] - The chairman must consult with the general manager and other senior management before proposing agenda items for regular meetings [2][3] - Temporary meetings can be called under specific circumstances, such as requests from shareholders or the chairman [2][3] Group 2: Meeting Notifications and Attendance - Notifications for regular meetings must be sent ten days in advance, while temporary meetings require five days' notice [3][4] - The meeting notice must include essential details such as time, location, and agenda items [4][5] - Directors are expected to attend meetings in person, but can delegate their attendance under certain conditions [5][6] Group 3: Voting and Decision-Making - Decisions require a majority vote from the attending directors, with specific rules for abstentions and conflicts of interest [8][10] - Proposals not passed cannot be reconsidered within a month unless significant changes occur [11] - The board must ensure that decisions are made within the authority granted by the shareholders and the company's articles of association [10][12] Group 4: Documentation and Record-Keeping - Meeting records must be accurate and include details such as attendance, proposals discussed, and voting results [12][14] - The board secretary is responsible for maintaining all meeting documentation for a minimum of ten years [14] - Any dissenting opinions must be documented, and confidentiality regarding the decisions is mandatory until official announcements are made [13][14]

广州维力医疗器械股份有限公司 董事、高级管理人员薪酬管理办法 广州维力医疗器械股份有限公司 董事、高级管理人员薪酬管理办法 （2025 年 8 月修订） 第一章 总则 第一条 为进一步完善广州维力医疗器械股份有限公司（以下简称"公 司"）董事、高级管理人员的薪酬管理，建立和完善经营者的激励约束机制， 保持核心管理团队的稳定性，有效地调动董事、高级管理人员的工作积极性， 提高公司经营管理水平，促进公司健康、持续、稳定发展，根据《中华人民共 和国公司法》《上市公司治理准则》《公司章程》等有关法律、法规的规定， 结合公司的实际情况，特制定本制度。 第二条 本制度适用于公司董事、高级管理人员。其所持本公司股份指登 记在其名下和利用他人账户持有的所有本公司股份，从事融资融券交易的，其 所持本公司股份还包括记载在其信用账户内的本公司股份。 第三条 公司薪酬制度遵循以下原则： （一）按岗位确定薪酬原则：公司内部各岗位薪酬体现各岗位对公司的价 值，体现"责、权、利"的统一； （二）按绩效评价标准、程序及主要评价体系的原则； （三）个人薪酬与公司长远利益相结合的原则； （四）激励与约束并重、奖罚对等的原则。 第二章 薪酬管理机 ...

广州维力医疗器械股份有限公司 章程 广州维力医疗器械股份有限公司 章程 （二〇二五年八月修订） | 第一章 | 总则 1 | | | --- | --- | --- | | 第二章 | 经营宗旨和范围 | 2 | | 第三章 | 股份 2 | | | 第一节 | 股份发行 | 2 | | 第二节 | 股份增减和回购 | 4 | | 第三节 | 股份转让 5 | | | 第四章 | 股东和股东会 | 6 | | 第一节 | 股东的一般规定 | 6 | | 第二节 | 控股股东和实际控制人 8 | | | 第三节 | 股东会的一般规定 | 9 | | 第四节 | 股东会的召集 | 12 | | 第五节 | 股东会的提案与通知 | 14 | | 第六节 | 股东会的召开 | 15 | | 第七节 | 股东会的表决和决议 | 18 | | 第五章 | 董事和董事会 | 22 | | 第一节 | 董事的一般规定 | 22 | | 第二节 | 独立董事 | 25 | | 第三节 | 董事会 | 29 | | 第四节 | 董事会专门委员会 | 34 | | 第六章 | 高级管理人员 | 35 | | 第七章 | 财务会计制 ...

广州维力医疗器械股份有限公司 对外投资管理制度 广州维力医疗器械股份有限公司 对外投资管理制度 （2025 年 8 月修订） 第一章 总则 第一条 为加强广州维力医疗器械股份有限公司（以下简称"公司"或"本公司"） 对外投资的管理，规范公司对外投资行为，提高投资效益，规避投资所带来的风险， 合理、有效的使用资金，使资金的时间价值最大化，依照《公司法》《证券法》《上 海证券交易所股票上市规则》《上海证券交易所上市公司自律监管指引第 5 号——交 易与关联交易》等法律、法规、规范性文件以及《公司章程》的有关规定，特制定本 制度。 第二条 本制度所称的对外投资是指公司为获取未来收益而将一定数量的货币 资金、股权、以及经评估后的实物或无形资产作价出资，对外进行各种形式的投资活 动。 第三条 按照投资期限的长短，公司对外投资分为短期投资和长期投资。短期投 资主要指公司购入的能随时变现且持有时间不超过一年（含一年）的投资，包括各种 股票、债券、基金、分红型保险等； 长期投资主要指投资期限超过一年，不能随时变现或不准备变现的各种投资，包 括债券投资、股权投资和其他投资等。包括但不限于下列类型： （一）公司独立兴办的企业或独 ...

广州维力医疗器械股份有限公司 股东会议事规则 广州维力医疗器械股份有限公司 股东会议事规则 第一章 总 则 第一条 为促进广州维力医疗器械股份有限公司（以下简称"公司"）规范 运作，提高股东会议事效率，保障股东合法权益，保证大会程序及决议内容的合 法有效性，根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中 华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》、 《广州维力医疗器械股份有限公司章程》（以下简称"公司章程"）等有关规定， 结合公司实际情况，制订本议事规则。 第二条 公司应当严格按照法律、行政法规、本规则及公司章程的相关规定 召开股东会，保证股东能够依法行使权利。 公司董事会应当切实履行职责，认真、按时组织股东会。公司全体董事应当 勤勉尽责，确保股东会正常召开和依法行使职权。 第三条 股东会应当在《公司法》和公司章程规定的范围内行使职权。 第四条 股东会分为年度股东会和临时股东会。年度股东会每年召开一次， 应当于上一会计年度结束后的六个月内举行。临时股东会不定期召开，出现《公 司法》第一百一十三条规定的应当召开临时股东会的情形时，临时股东会应当在 二个月内召开。 公司在 ...